AU5093898A - Primers for amplification of brca1 - Google Patents
Primers for amplification of brca1Info
- Publication number
- AU5093898A AU5093898A AU50938/98A AU5093898A AU5093898A AU 5093898 A AU5093898 A AU 5093898A AU 50938/98 A AU50938/98 A AU 50938/98A AU 5093898 A AU5093898 A AU 5093898A AU 5093898 A AU5093898 A AU 5093898A
- Authority
- AU
- Australia
- Prior art keywords
- brca1
- primers
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2920896P | 1996-10-31 | 1996-10-31 | |
US60029208 | 1996-10-31 | ||
PCT/US1997/019596 WO1998018966A1 (en) | 1996-10-31 | 1997-10-31 | Primers for amplification of brca1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5093898A true AU5093898A (en) | 1998-05-22 |
Family
ID=21847811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50938/98A Abandoned AU5093898A (en) | 1996-10-31 | 1997-10-31 | Primers for amplification of brca1 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5093898A (en) |
WO (1) | WO1998018966A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3087801A (en) * | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622829A (en) * | 1993-12-08 | 1997-04-22 | The Regents Of The University Of California | Genetic markers for breast, ovarian, and prostatic cancer |
US5693473A (en) * | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
US5654155A (en) * | 1996-02-12 | 1997-08-05 | Oncormed, Inc. | Consensus sequence of the human BRCA1 gene |
-
1997
- 1997-10-31 AU AU50938/98A patent/AU5093898A/en not_active Abandoned
- 1997-10-31 WO PCT/US1997/019596 patent/WO1998018966A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998018966A1 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3116497A (en) | Subtractive amplification | |
AU2438297A (en) | Combinations of angiostatic compounds | |
AU3998195A (en) | Multiplex amplification of short tandem repeat loci | |
AU3225897A (en) | Regulation of gene expression | |
AU9128798A (en) | Genotyping of human cyp3a4 | |
AU5100599A (en) | Egf-genistein for prevention of restenosis | |
AU2448797A (en) | Methods of providing neuroprotection | |
AU5525998A (en) | Target-triggered amplification | |
AU4296397A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AU3769097A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AU2646497A (en) | Amplification of nucleic acids | |
AU4909797A (en) | 3-carboxamide derivatives of 5H-pyrrolo(2,1-c)(1,4)- benzodiazepines | |
AU2217797A (en) | Synthesis of indolylmaleimides | |
AU3093697A (en) | Aminophthalic acid derivatives | |
AU4248297A (en) | Inhibition of viral replication | |
AU1600597A (en) | Stabilisation of polyolefin-recyclates | |
EP0832641A3 (en) | Derivatives of bezoxazole useful as uv stabilizers | |
AU4157097A (en) | Synthesis of bisindolylmalimides | |
AU1750497A (en) | Compounds capable of inhibiting hiv-1 infection | |
AU3467697A (en) | 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same | |
AU4917397A (en) | Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase | |
AU1082701A (en) | Short segments of dap-kinase | |
AU4229197A (en) | Treatment of equine protozoal myeloencephalitis | |
AU3191597A (en) | Novel medicinal compositions of hydropyridines | |
AU3906997A (en) | Novel heterocycle compositions |